Clinical Trial Update: Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on pericapsular nerve group block chemical neurolysis for advanced hip osteoarthritis; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Hip

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Osteoarthritis, Osteoarthritis, Hip | Phase 4 | Status: COMPLETED